Delek Group, Ltd. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 258 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Delek Group, Ltd. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$7,423,000
+114.7%
50,000
+62.1%
0.29%
+81.6%
Q4 2018$3,457,000
+72.7%
30,850
+14.3%
0.16%
+53.4%
Q1 2018$2,002,000
-2.6%
26,998
-27.0%
0.10%
-6.4%
Q4 2017$2,056,00036,9980.11%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders